No Data
No Data
Hitgen Inc. (688222.SH): Its wholly-owned subsidiary in the United Kingdom received a government subsidy of 1.0499 million British pounds.
According to Gelonghui on September 12th, HitGen Inc. (688222.SH) announced that its wholly-owned subsidiary Vernalis (R&D) Limited in the United Kingdom recently received government grants of 1.0499 million British pounds (equivalent to 949.23 million. 95 yuan in RMB), all of which are government grants related to income.
HitGen's (SHSE:688222) Earnings Offer More Than Meets The Eye
Hitgen Inc.: The main business in the first half of the year has achieved steady progress, and the ability to innovate has enhanced the long-term development resilience.
On the evening of August 28th, 2024, Hitgen Inc., a star-listed company on the Shanghai Stock Exchange's Star Exchange (referred to as "Hitgen" or "the Company", stock code: 688222.SH), released its 2024 interim report (referred to as "Interim Report"). In the first half of 2024, Hitgen continuously optimized its international and domestic market strategies, achieved more precise market positioning and more efficient business operations through cross-market resource sharing and complementary advantages, and deepened cooperation with multiple global partners.
Chengdu Pilot Drug Development Co., Ltd. 2024 Semi-Annual Report
Summary of the 2024 semi-annual report of Chengdu Pilot Drug Development Co., Ltd.
hitgen inc. (688222.SH) released its semi-annual performance with a net income of 10.2 million yuan, a year-on-year increase of 75.19%.
hitgen inc. (688222.SH) disclosed its 2024 interim report, and the company achieved a revenue of 1.95...
No Data
No Data